Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Mangalam Drugs and Organics Annual General Meeting

Mangalam Drugs and Organics seeks shareholder approval via postal ballot for Shri Praveen Saxena's re-appointment. E-voting commences May 19, 2026, for a second five-year term.

Key figures
Execution period5 years
Source

BSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Mangalam Drugs and Organics Ltd: key numbers

Share price
₹29.11
Market cap
₹46.08 Cr
Revenue (annual)
₹232.1 Cr
Net profit (annual)
₹-44.40 Cr
P/E (TTM)
-1.2×Sector 46.1×
Promoter holding
35.65%+0.00% QoQ
FII holding
0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mangalam Drugs and Organics Ltd

All →

Other annual general meeting announcements

All →